These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. [Expression of TFAR19(PDCD5) in normal human kidney, renal clear cell carcinoma, normal human bladder and bladder carcinoma]. Xiong L; Tan WL; Yu ZC; Wu YD; Huang H; Zhao GZ; Zhu WH; Zheng SB Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):805-9. PubMed ID: 16793605 [TBL] [Abstract][Full Text] [Related]
32. Novel molecular targets for the therapy of renal cell carcinoma. Elfiky AA; Sonpavde G Discov Med; 2012 Jun; 13(73):461-71. PubMed ID: 22742652 [TBL] [Abstract][Full Text] [Related]
33. Imprint cytological findings of acquired cystic disease-associated renal-cell carcinoma: a close relationship to papillary renal-cell carcinoma. Yamaguchi T; Kuroda N; Kawada T; Imamura Y Diagn Cytopathol; 2012 Sep; 40(9):844-6. PubMed ID: 21681973 [No Abstract] [Full Text] [Related]
34. Sarcomatoid renal cell carcinoma with osteosarcomatous differentiation--a case report. Handoo A; Pai RR; Rao VS; Sanjeeva VB Indian J Pathol Microbiol; 2004 Oct; 47(4):528-9. PubMed ID: 16295385 [TBL] [Abstract][Full Text] [Related]
35. Re: Anders Lidgren, Ylva Hedberg, Kjell Grankvist, Torgny Rasmuson, Anders Bergh and Börje Ljungberg. Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray. Eur Urol 2006;50:1272-7. Minervini A; Di Cristofano C; Serni S; Carini M Eur Urol; 2007 May; 51(5):1451-2; author reply 1452-3. PubMed ID: 17239525 [No Abstract] [Full Text] [Related]
36. Ghrelin expression in normal kidney tissue and renal carcinomas. Dagli AF; Aydin S; Karaoglu A; Akpolat N; Ozercan IH; Ozercan MR Pathol Res Pract; 2009; 205(3):165-73. PubMed ID: 19054628 [TBL] [Abstract][Full Text] [Related]
37. [A case of erythropoietin-producing renal cell carcinoma with polycythemia]. Okuyama M; Nishihara M; Hashimoto H; Kaneko S; Yachiku S Hinyokika Kiyo; 2002 Sep; 48(9):531-4. PubMed ID: 12402477 [TBL] [Abstract][Full Text] [Related]
38. What do we need for eradicating kidney cancer cells? Oya M Int J Urol; 2012 Feb; 19(2):96-7. PubMed ID: 22168349 [No Abstract] [Full Text] [Related]
39. Salivary gland-type renal carcinoma, a subset of collecting duct carcinoma: case report and meta-analysis of the entity. Williams PA; Mai KT Histopathology; 2013 Feb; 62(3):514-8. PubMed ID: 23339365 [No Abstract] [Full Text] [Related]
40. [Expression of Fas ligand in urogenital malignant cell lines and renal cell carcinoma]. Li H; Yu L; Guo Y; Ding Y; Liu L Zhonghua Wai Ke Za Zhi; 2000 Mar; 38(3):201-3. PubMed ID: 11832029 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]